Overview
Reducing Blood Loss During Cesarean Myomectomy With Tranexamic Acid
Status:
Completed
Completed
Trial end date:
2020-03-01
2020-03-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
This study was a double-blinded randomized controlled study conducted at Aswan University, Egypt from January 2018 to January 2020. Study inclusion criteria were women who attended the outpatient obstetric clinic, seeking antenatal care diagnosed with leiomyomas with pregnancy and with myoma staging from (3 to 6) according to FIGO staging. scheduled to undergo cesarean myomectomy (11) Exclusion criteria were: 1-Patients undergone vaginal delivery.2-Patients with a history of thromboembolic disease. 3-Cervical and broad ligament myoma. 4-Myoma FIGO stagingPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Aswan University HospitalTreatments:
Tranexamic Acid
Criteria
Inclusion Criteria:- women who attended the outpatient gynecology clinic, seeking treatment for symptomatic
leiomyomas and scheduled to undergo abdominal myomectomy with myoma staging from (3 to
6) according to FIGO staging
Exclusion Criteria:
1. Patients undergone vaginal or laparoscopic myomectomy.
2. Patients received preoperative embolization or gonadotrophin releasing hormone analog.
3. Cervical and broad ligament myoma.
4. Patients with cardiac, hepatic, renal or thromboembolic disease
5. patients had an allergy to tranexamic acid).